Introduction {#s0010}
============

Gallbladder cancer (GBC) is the fifth most common gastrointestinal tract malignancy in the United States, with an incidence of 6500 cases annually [@bib0010]. Known risk factors for GBC include chronic cholelithiasis, female gender (ratio approximately 3:1), porcelain gallbladder, adenomatous polyposis of the gallbladder (GB), carcinogens (eg, miners exposed to radon), *Salmonella typhi* infection, and abnormal pancreaticobiliary duct junction [@bib0010]. Although only up to 3% of patients with cholelithiasis develop gallbladder cancer, gallstones are present in 70%-90% of patients diagnosed with GBC [@bib0010]. Chronic irritation of the GB wall related to gallstones is hypothesized to be the major risk factor for malignant transformation of the GB epithelium. Approximately 80%-95% of primary gallbladder cancers are adenocarcinoma (AC) [@bib0015]. Other histologic types include small cell cancer, squamous cell carcinoma (SCC), lymphoma, and sarcoma.

Patients with GBC are usually asymptomatic in the absence of advanced disease. As a result, diagnosis and management can be challenging. Patients can often present with symptoms such as anorexia, abdominal pain, nausea, and vomiting, which may be indistinguishable from those of acute cholecystitis [@bib0020]. Findings that are more specific for advanced disease include weight loss, obstructive jaundice (secondary to tumor invasion of the intrahepatic bile ducts or hepatic metastases), ascites, palpable abdominal mass, and hepatomegaly. Computed tomography and ultrasonography results are often consistent with acute cholecystitis and cholelithiasis. Thus, most cases are diagnosed intraoperatively.

Case report {#s0015}
===========

A 37-year-old previously healthy Caucasian female presented initially with progressive right upper quadrant (RUQ) abdominal pain and pruritus. Her pain became increasingly worse 2 days prior to presentation. Review of systems revealed jaundice, scleral icterus, pruritus, fatigue, light-colored stools, and progressive abdominal distension, despite not having made any dietary modifications. She did not report weight loss, fever, chills, nausea, or vomiting. Social history reveals social alcohol consumption and a light tobacco smoking history. On examination, she was jaundiced, with a palpable RUQ mass. Her abdomen was soft and nontender. Laboratory findings demonstrated a WBC count of 7100/µL (normal: 3.8-10.5 K/µL), total bilirubin (T. Bili) of 7.3 mg/dL (Normal: 0.2-1.2 mg/dL), direct bilirubin (D. Bili) of 5.7 mg/dL (Normal: ≤0.2 mg/dL), alkaline phosphatase (Alk Phos) of \>1000 U/L (Normal: 40-120 U/L), and Ca 19-9 of 45.0 U/mL (Normal: ≤41.3 U/mL). The initial computed tomography scan of the abdomen was interpreted to include intrahepatic biliary ductal dilatation, a dilated stone-filled GB up to 6.4 cm in diameter with an abnormally thickened wall up to 0.6 cm, and pericholecystic fluid, which was concerning for acute cholecystitis or choledocholithiasis. There was also an 8.4 cm heterogeneous soft tissue mass within the liver with an infiltrative component adjacent to the GB fossa ([Fig. 1](#f0010){ref-type="fig"}, [Fig. 2](#f0015){ref-type="fig"}). A corresponding MRI demonstrated a focal defect in the anterior GB wall adjacent to the right hepatic lobe, likely related to GB wall necrosis in this region/acute gangrenous cholecystitis. Also noted was common hepatic duct (CHD) obstruction and a large 7.6-cm lesion in hepatic segment 4B, as well as a second smaller lesion within segment 5, which did not enhance with gadolinium ([Fig. 3](#f0020){ref-type="fig"}, [Fig. 4](#f0025){ref-type="fig"}, [Fig. 5](#f0030){ref-type="fig"}). As a result, a likely diagnosis of hepatic abscesses was given with consideration for a superimposed infiltrative neoplastic process.Fig. 1Coronal contrast-enhanced CT image of the abdomen demonstrates gallbladder wall thickening, pericholecystic hepatic lesions (tumor invasion), intrahepatic biliary ductal dilatation, as well as a soft tissue peritoneal lesion adjacent to the gallbladder (arrow). CT, computed tomography.Fig. 1Fig. 2Axial contrast-enhanced CT image demonstrates large hypodense hepatic lesions, a distended gallbladder neck with stones (arrow), and intrahepatic biliary ductal dilatation. CT, computed tomography.Fig. 2Fig. 3Coronal T2-weighted MIP image of the biliary tree demonstrating CHD obstruction (arrow). CHD, common hepatic duct; MIP, maximum intensity projection.Fig. 3Fig. 4Axial T1-weighted precontrast image demonstrates heterogeneous, predominantly hypointense hepatic lesions, a peritoneal lesion (arrow), and cholelithiasis within the gallbladder.Fig. 4Fig. 5MRI: (A) Axial diffusion-weighted image demonstrates restricted diffusion within the periphery of one of the hepatic lesions (arrow). There is cholelithiasis within a distended gallbladder neck. (B) Axial T1-weighted contrast enhanced image (5-minute delay) demonstrates hepatic lesions with peripheral enhancement and central hypointensity (arrow).Fig. 5

Interventional radiology was consulted for placement of a cholecystostomy tube and drainage of hepatic abscesses. A cholecystostomy was placed with aspiration of approximately 150 cc of purulent bilious fluid. A large hypoechoic lesion in hepatic segment 4 was accessed and a drain was placed with aspiration of only a few cc of purulent fluid. Gram stain and culture of both specimens showed no growth of organisms.

Despite placement of a cholecystostomy tube and hepatic drain, T. bili remained elevated up to 7.9 mg/dL over the following 3 days. As a result, an ultrasound was obtained which redemonstrated a persistently dilated GB with an appropriately positioned cholecystostomy, a thickened GB wall, and multiple heterogeneous hepatic lesions, which were thought to be phlegmon or developing abscesses ([Fig. 6](#f0035){ref-type="fig"}). Gastroenterology (GI) was consulted and performed an endoscopic retrograde cholangiopancreatography (ERCP) with placement of a pancreatic duct stent as well as CHD stent placement for a visualized stricture. A CHD biliary brushing was performed at the time which was negative for malignant cells. Following the ERCP, her diet was advanced, her T. bili trended down to 3.3 mg/dL, and her WBC remained in normal range prior to discharge home.Fig. 6Ultrasound images: (A) Markedly dilated intrahepatic biliary ducts within the left hepatic lobe. (B) Marked gallbladder wall thickening, cholelithiasis, and adjacent hypoechogenic hepatic lesions or invasion.Fig. 6

She presented again 1 month later with 1 day of severe RUQ abdominal pain. A repeat ERCP was performed with brushings of the CHD stricture which returned suspicious for SCC. The decision was made to perform a laparoscopic cholecystectomy. The previously seen peritoneal soft tissue mass adjacent to the GB was biopsied and sent for frozen section, which showed SCC. The gallbladder was resected. Histologic examination of the GB demonstrated stage T3NxM1 moderately differentiated invasive SCC with extensive necrosis involving the entire GB, as well as local invasion to the peritoneum and metastasis to the omentum ([Fig. 7](#f0040){ref-type="fig"}, [Fig. 8](#f0045){ref-type="fig"}). A few microscopic foci of AC were also seen (\<1% of total tumor volume). The patient was discharged to follow-up with another facility for further treatment.Fig. 7Microscopic pathology: (A) Nerve (green arrow) is surrounded and invaded by tumor nests (perineural invasion). (B) Lymphatic channel (green arrow) with tumor nest inside (lymphovascular invasion).Fig. 7Fig. 8Extensive areas of tumor necrosis are identified (green arrow).Fig. 8

Discussion {#s0020}
==========

Primary SCC of the gallbladder is a rare entity that comprises between 1-3% of all primary GB cancers [@bib0025], [@bib0030]. There is a poorer prognosis associated with primary SCC of the gallbladder when compared to the more common AC variant because it is thought to be more locally invasive, and is typically diagnosed at a more advanced T stage [@bib0015], [@bib0025], [@bib0035]. The overall mean survival rate for patients with GBC is 6 months, with a 5-year survival rate of 5% [@bib0020]. The gallbladder lacks a serosal layer between the gallbladder and liver, which increases susceptibility for local hepatic tumor invasion. This is why early diagnosis of primary SCC of the GB is critical for improved patient outcomes.

Song et al. demonstrate in their analysis of 411 patients with GBC, that there is no statistically significant difference of percentage of patients with normal or elevated Ca-19-9 levels. It cannot be reliably used as an indicator for disease, however, a larger number of patients with GBC had a CA-19-9 level \>37 (U/mL) [@bib0015]. Song et al. also reported a median follow-up time of 21 months and demonstrated that patients with mixed adenosquamous carcinoma (ASC)/SCC differentiation had a median survival of 3.3 months compared to 6.0 months in the AC variant [@bib0015]. However, Kalayarasan et al. (136 patients) found no significant difference in survival rates between patients with SCC/ASC vs AC [@bib0035]. A summary of recently reported cases of SCC of the GB is presented ([Table 1](#t0010){ref-type="table"}**)**.Table 1Summary of recently reported cases of SCC of the gallbladderTable 1ReferenceNo. of patientsAgeGenderPresentationImaging findings/diagnostic modality (Dx)PathologyInvolvementSurvival (mo)Alpuerto et al. (2017) [@bib0025]175FRUQ pain, WBC (15,000/µL), and Normal Liver Function Tests (LFTs)CT: GB wall thickening, pericholecystic fluid, irregular soft tissue mass in GB fundus\
US: 3.8 cm Heterogeneous GB fundal lesion with small calcifications\
Dx: Cholecystectomy, duodenal/stomach resectionPure 1° SCC of the GB\
T4NxMxLocal invasion of the liver, duodenum, and stomachAlive at the time\
of publicationChandna et al. (2016) [@bib0040]170FDyspepsia, RUQ pain, icterus, and no palpable massCT: Not performed\
US: Gallstones with a thickened irregular GB wall\
Dx: CholecystectomyKeratinizing SCC confined to the serosaLocally resected tumor with negative marginsNot reportedHoshimoto et al. (2016) [@bib0045]3 SCC\
1 ASCMean of 682:2\
(M:F)Not reportedImaging findings were not reportedSCC (40%-90%)\
T2 and T3 stagesLocal invasion of the liverNot reportedKalayarasan et al. (2013) [@bib0035]4 (SCC)\
10 (ASC[a](#sp9015){ref-type="fn"})Median of 491:2.5\
(M:F)Abdominal pain, emesis, and palpable RUQ massImaging was performed but findings are not reported\
Dx: Staging laparoscopy and tumor resectionSCC/ASC stage T3 (43%) or T4 (57%)Local invasion of the duodenum, CBD, liver, and colonMedian of 28Khan et al. (2012) [@bib0050]135FR-sided abdominal pain, palpable RUQ massCT/US: Enlarged GB up to 8.4 cm, thickened GB wall up to 0.8 cm, an 8-cm solid hepatic mass within the right hepatic lobe, and cholelithiasis\
Dx: Cholecystectomy and partial hepatectomyPure SCC\
stage T4N0MxLocal invasion of the liver and omentumNot reportedMghirbi et al. (2016) [@bib0030]167FRUQ pain, 15 kg weight loss, and palpable RUQ massCT: 8-cm solid cystic mass of the GB bed with intrinsic calcifications and extension into the adjacent liver parenchyma\
US: 10-cm heterogeneous GB mass with echogenic center and hepatic invasion\
Dx: Colonoscopic biopsy of a right colon lesionSCC of the GB (R colon biopsy)\
T4NxMxLocal invasion of the liver and right colonNot reportedRoa et al. (2011) [@bib0055]8 (SCC)\
26 (ASC[a](#sp9015){ref-type="fn"})Mean of 657:27\
(M:F)Specific presenting symptoms not includedImaging was performed but findings are not reported\
Dx: Most cases following cholecystectomy for suspected acute cholecystitisSCC/ASC stage T2, T3 (68%), and T4 at diagnosisLocal invasion of the duodenum, CBD, liver, stomach, and colonASC[a](#sp9015){ref-type="fn"} mean of 23\
Adeno mean of 50Song et al. (2015) [@bib0015]10 (SCC)\
24 (ASC[a](#sp9015){ref-type="fn"})Mean of 61.410:24 (M:F)Included abdominal pain, jaundice, weight loss, and palpable massImaging was performed but findings are not reported\
Dx: Tumor resectionSCC/ASC stage T3 (38%) or T4 (62%)88.2% with liver invasionMedian of 3.3Levy et al. (2017) (this study)137FAbdominal pain/distension, jaundice, pruritus, fatigue, pale stools, and palpable RUQ massCT: Intrahepatic biliary ductal dilatation, dilated GB with thickened wall, an 8-cm heterogeneous liver mass, and cholelithiasis\
US: Multiple heterogeneous hepatic lesions thought to be abscesses\
MRI: CHD biliary obstruction and 7.6-cm nonenhancing hepatic lesionSCC (\<1% adenocarcinoma)\
T3NxM1Local invasion of the liver, peritoneum, and metastasis to the omentumAlive at the time\
of publication[^1][^2]

Radiographic features suspicious for gallbladder cancer include: intraluminal mass, diffuse mural thickening, mass replacing the gallbladder (present in 40-65% of cases at initial detection), intra-hepatic biliary ductal dilatation, and hepatic lesions adjacent to the gallbladder fossa [@bib9010]. More advanced features include peritoneal carcinomatosis, lymphadenopathy, and hepatic/distant metastases. Once we identify suspicious features, it is important to correlate with the history and imaging features for suspicious signs and symptoms, as well as risk factors.

The differential diagnosis for findings suspicious for gallbladder cancer include: gallbladder polyp, gallbladder wall thickening/edema (secondary to adenomyomatosis, portal hypertenion, hepatitis, infectious mononucleosis, congestive heart failure, renal failure, and pancreatitis), cholecystitis (including acute calculous, acalculous, chronic, and xanthogranulomatous variants), bile duct tumors, biliary obstruction, cholangiocarcinoma, hepatocellular carcinoma, gallbladder volvulus, and liver abscess.

As radiologists, it is important to keep GBC on the differential for patients with gallbladder wall thickening, intra-hepatic biliary ductal dilatation, and/or adjacent hepatic lesions. It is also important to assess for regional lymphadenopathy. Although it has been described, regional lymphadenopathy is seldom reactive secondary to acute cholecystitis. However, there may be a rare instance where lymphadenopathy is present secondary to a superimposed infection such as infectious mononucleosis or a systemic lymphoproliferative disorder [@bib9015]. Albeit the SCC variant does not typically demonstrate local lymph node involvement, the more common AC variant does, and the presence of lymphadenopathy should increase suspicion for malignancy. The patient\'s risk factors should also be assessed to determine likelihood for GB cancer. Our patient\'s known risk factors are chronic cholelithiasis and female gender. Care should also be made to obtain as much history as possible because the provided history is often meager. The synthesis of both imaging features and clinical history should lead you to suspect GBC.

Supplementary data {#s0030}
==================

The following is the supplementary data to this article:Video S1CT axial.Video S1

Video S2MRI diffusion.Video S2

Video S3MRI ADC.Video S3

Video S4MRI axial T1.Video S4

Video S5MRI axial T2.Video S5

Video S6MRI axial T1 post contrast.Video S6
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[^1]: ASC, adenosquamous carcinoma; CBD, common bile duct; CHD, common hepatic duct; CT, computed tomography; Dx, diagnosis; GB, gallbladder; RUQ, right upper quadrant; SCC, squamous cell carcinoma; US, ultrasound; WBC, white blood cell.

[^2]: ASC, adenosquamous differentiation (composed of cases with adenocarcinoma with more than 30%^a^ or 25%^b,c^ of the SCC component).
